Sleep apnea treatment: FDA approves Remedē System implantable device

The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The RemedA System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing. "This implantable device ["]

The post Sleep apnea treatment: FDA approves RemedA System implantable device appeared first on Outbreak News Today.